BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16310984)

  • 1. Relationship between
    Babaki A; Zare Mehrjardi E; Dehghani Firouzabadi R; Aflatoonian A; Seifati SM
    Int J Reprod Biomed; 2018 Oct; 16(10):637-640. PubMed ID: 30643856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTM1 and GSTT1 Polymorphisms and Susceptibility to Prostate Cancer: A Case-Control Study of the Algerian Population.
    Benabdelkrim M; Djeffal O; Berredjem H
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2853-2858. PubMed ID: 30362312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen.
    Mehboob H; Tahir IM; Iqbal T; Saleem S; Perveen S; Farooqi A
    Dose Response; 2017; 15(3):1559325817723731. PubMed ID: 28932176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
    Jin SE; Seo CS; Shin HK; Ha H
    Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pungent ginger components modulates human cytochrome P450 enzymes in vitro.
    Li M; Chen PZ; Yue QX; Li JQ; Chu RA; Zhang W; Wang H
    Acta Pharmacol Sin; 2013 Sep; 34(9):1237-42. PubMed ID: 23770984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Acetyltransferase 1 (NAT1) Genotype: A Risk Factor for Urinary Bladder Cancer in a Lebanese Population.
    Yassine IA; Kobeissi L; Jabbour ME; Dhaini HR
    J Oncol; 2012; 2012():512976. PubMed ID: 22956951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.
    Hulin-Curtis SL; Petit D; Figg WD; Hsing AW; Reichardt JK
    Future Oncol; 2010 Dec; 6(12):1897-913. PubMed ID: 21142863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A generalized physiologically-based toxicokinetic modeling system for chemical mixtures containing metals.
    Sasso AF; Isukapalli SS; Georgopoulos PG
    Theor Biol Med Model; 2010 Jun; 7():17. PubMed ID: 20525215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene--environment-wide association studies: emerging approaches.
    Thomas D
    Nat Rev Genet; 2010 Apr; 11(4):259-72. PubMed ID: 20212493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling and its practice in drug development.
    Chengalvala MV; Chennathukuzhi VM; Johnston DS; Stevis PE; Kopf GS
    Curr Genomics; 2007 Jun; 8(4):262-70. PubMed ID: 18645595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M; Pelkonen O
    IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.
    Wormhoudt LW; Commandeur JN; Vermeulen NP
    Crit Rev Toxicol; 1999 Jan; 29(1):59-124. PubMed ID: 10066160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of toxic reactions to drugs and chemicals.
    Cascorbi I
    Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
    Gresner P; Gromadzinska J; Wasowicz W
    Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.